CINECA IRIS Institutional Research Information System

High-Dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: Results of the EORTC-GIMEMA AML-12 trial

MELONI, GIOVANNA ROBERTA;MANCINI, Marco;CILLONI, Daniela;
2014-01-01
2014
32
3
219
228
http://jco.ascopubs.org/content/32/3/219.full.pdf+html
Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Europe; Female; Humans; Induction Chemotherapy; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Risk Assessment; Risk Factors; Treatment Outcome; Cancer Research; Oncology; Medicine (all)
Willemze, Roelof; Suciu, Stefan; Meloni, Giovanna; Labar, Boris; Marie, Jean-Pierre; Halkes, Constantijn J. M.; Muus, Petra; Mistrik, Martin; Amadori,...espandi
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
cilloni 1550110.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 284.05 kB
Formato Adobe PDF
Visualizza/Apri
284.05 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1550110
Citazioni
  • ???jsp.display-item.citation.pmc??? 66
  • Scopus 142
  • ???jsp.display-item.citation.isi??? 129
social impact